COMMUNIQUÉS West-GlobeNewswire

American teacher undergoes cardiac treatment in Xiamen
14/10/2025
XIAMEN, China , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Kevin Klein, an American teacher from Xiamen International School, underwent coronary angiography and radio-frequency ablation on Sep 26 at the Xiamen Cardiovascular [...]
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases
14/10/2025
Press Release EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases Through this funding round, the company will initiate the clinical development of its first therapeutic candidate, [...]
Dewpoint Therapeutics Announces Presentation at AACR-NCI-EORTC 2025
14/10/2025
Dewpoint will present one poster at AACR-NCI-EORTC MYC is a highly desirable oncogenic target that historically eluded drug hunters Small molecules that inhibit the oncogenic function of MYC were discovered using [...]
HIV Self-Testing Just Got Faster: FDA Approves the 1-Minute INSTI® HIV Self Test
14/10/2025
The fastest, at-home HIV test is now available in the U.S., expanding access to rapid, private, and convenient self-testing A Major Step Forward in HIV Prevention The INSTI ® HIV Self Test delivers highly accurate [...]
Bicycle Health Grows Leadership Team to Further Expand Access to Opioid Use Disorder Care for Patients in the Criminal Justice System
14/10/2025
Steve Tomlin has decades of experience bringing opioid and substance use disorder care to criminal justice populations BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Bicycle Health , the nation’s largest provider of virtual [...]
Rendever Leads Expansion of Virtual Reality in Hospice Care
14/10/2025
The AgeTech company expands hospice partnerships to enhance end-of-life care with immersive experiences for patients and families BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Rendever , the company leading the industry in [...]
Imprivata Acquires Verosint to Add AI-Powered Risk Signaling to its Leading Enterprise Access Management Platform
14/10/2025
Integration of Verosint Identity Threat Detection & Response with Imprivata Enterprise Access Management will strengthen the company’s advanced and passwordless access strategy to bolster security, improve workflow [...]
ZymoChem Named Startup of the Year by The International Textile Manufacturers Federation
14/10/2025
SAN LEANDRO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- ZymoChem , the materials company decarbonizing the chemical industry through biological manufacturing, announces its recognition as a Startup of the Year by The [...]
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
14/10/2025
LOS ANGELES, CA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present and [...]
Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease
14/10/2025
First-in-class regenerative therapy for diabetic foot ulcers complicated by peripheral artery disease Celularity PDA-002 achieved durable wound healing with just two intramuscular doses As a qualified stem cell therapy [...]
Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze
14/10/2025
– Parties enter into Restructuring Support Agreement; Vireo to bid to acquire control of Schwazze assets – – Schwazze operates 63 dispensaries and 10 manufacturing facilities in Colorado and New Mexico – MINNEAPOLIS, [...]
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
14/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
14/10/2025
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans SAN FRANCISCO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of [...]
LB Pharmaceuticals Appoints James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs
14/10/2025
NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced the appointment of James Rawls, Pharm.D., as Senior Vice President of Regulatory [...]
BPGbio Welcomes Sheikh Dr. Khalid Bin Jabor Al Thani as Executive in Residence
14/10/2025
Distinguished cancer leader to advise BPGbio leadership on acceleration of NAi platform globally and BPM 31510 oncology franchise for Precision Oncology Initiatives BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc [...]
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
14/10/2025
Non-inferiority trial versus PAXLOVID ® assessing safety and efficacy, including rates of disease rebound and incidence of Long COVID development, of ratutrelvir, a ritonavir-free anti-viral treatment Separate single- [...]
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025
14/10/2025
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems [...]
I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
14/10/2025
The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held October 22-26 in Boston, Massachusetts ROCKVILLE, Md., Oct. 14, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ:IMAB) (the [...]
Assembly Biosciences Announces Upcoming Investor Conference Participation
14/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that [...]

Pages